|
US2981731A
(en)
|
|
1961-04-25 |
|
Acridine derivatives |
|
US2985661A
(en)
|
1956-02-06 |
1961-05-23 |
American Cyanamid Co |
Preparation of 2(omicron-aminophenyl)-benzimidazole
|
|
US2915523A
(en)
|
1956-12-03 |
1959-12-01 |
Parke Davis & Co |
Benzacridine compounds
|
|
US3272707A
(en)
|
1964-07-17 |
1966-09-13 |
Smith Kline French Lab |
Pharmaceutical compositions and methods for their use
|
|
CH420045A
(de)
|
1964-09-01 |
1967-03-15 |
Ciba Geigy |
Verwendung von neuen Poly-azolen als optische Aufhellmittel für textile organische Materialien
|
|
US3267107A
(en)
|
1964-09-17 |
1966-08-16 |
American Home Prod |
3-(4'-5'-methylenedioxy-phenyl)-7, 8-dimethoxy-1, 2, 3, 4,-tetrahydroisoquinolines
|
|
US3849561A
(en)
|
1964-10-20 |
1974-11-19 |
S Naruto |
Anti-peptic ulcer substance from corydalis tubers
|
|
DE1670684A1
(de)
|
1966-04-01 |
1970-12-03 |
Hoechst Ag |
Verfahren zur Herstellung von basisch substituierten Bis-benzimidazol-derivaten
|
|
US3542782A
(en)
|
1967-03-15 |
1970-11-24 |
Sandoz Ag |
5,6-dihydro-8h-isoquino(1,2-b)quinazolines
|
|
JPS4942700A
(cg-RX-API-DMAC7.html)
|
1972-08-25 |
1974-04-22 |
|
|
|
US3912740A
(en)
|
1974-02-28 |
1975-10-14 |
Us Health |
Method for the preparation of oxygenated benzo{8 c{9 phenanthridine compounds
|
|
PT73763B
(fr)
|
1981-10-01 |
1983-10-26 |
Quatrum Empresa Nacional De Qu |
Procede pour la preparation de nouveaux epoxides d'alkaloides benzofenantridiniques et de compositions pharmaceutiques qui les contiennent
|
|
US5153178A
(en)
|
1982-05-14 |
1992-10-06 |
Maroko Peter R |
Compositions and method of treatment for improving circulatory performance
|
|
IE55519B1
(en)
|
1982-05-14 |
1990-10-10 |
Maroko Peter R |
Use of a protoberberine alkaloid and composition containing same
|
|
US4749708A
(en)
|
1982-05-14 |
1988-06-07 |
Maroko Peter R |
Composition for improving circulatory performance
|
|
US4980344A
(en)
|
1982-05-14 |
1990-12-25 |
Maroko Peter R |
Compositions for improving circulatory performance
|
|
US4761417A
(en)
|
1982-05-14 |
1988-08-02 |
Maroko Peter R |
Compounds, compositions and method of treatments for improving circulatory performance
|
|
US4559157A
(en)
|
1983-04-21 |
1985-12-17 |
Creative Products Resource Associates, Ltd. |
Cosmetic applicator useful for skin moisturizing
|
|
LU84979A1
(fr)
|
1983-08-30 |
1985-04-24 |
Oreal |
Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
|
|
JPS61130289A
(ja)
|
1984-11-29 |
1986-06-18 |
Ss Pharmaceut Co Ltd |
13−プロピルベルベリンの塩
|
|
FR2595356B1
(fr)
|
1986-03-05 |
1991-05-24 |
Pasteur Strasbourg Universite |
Derives des nitro ou aminobenzyltetrahydroisoquinoleines, procedes d'obtention, compositions pharmaceutiques les contenant, proprietes pharmacologiques et applications
|
|
US5244903A
(en)
|
1987-03-31 |
1993-09-14 |
Research Triangle Institute |
Camptothecin analogs as potent inhibitors of topoisomerase I
|
|
US4820508A
(en)
|
1987-06-23 |
1989-04-11 |
Neutrogena Corporation |
Skin protective composition
|
|
SU1530628A1
(ru)
|
1987-11-20 |
1989-12-23 |
Ленинградский Технологический Институт Им.Ленсовета |
Тригидрохлорид 2-[2-фенил-5(6)-бензимидазолил]-N-(3-диметиламинопропил)-5(6)-бензимидазолкарбоксамида в качестве флуоресцентного красител дл исследовани ДНК
|
|
US4992478A
(en)
|
1988-04-04 |
1991-02-12 |
Warner-Lambert Company |
Antiinflammatory skin moisturizing composition and method of preparing same
|
|
US4938949A
(en)
|
1988-09-12 |
1990-07-03 |
University Of New York |
Treatment of damaged bone marrow and dosage units therefor
|
|
US5106863A
(en)
|
1990-03-26 |
1992-04-21 |
Ortho Pharmaceutical Corporation |
Substituted imidazole and pyridine derivatives
|
|
US5135934A
(en)
|
1990-07-06 |
1992-08-04 |
Du Pont Merck Pharmaceutical Company |
3-phenyl-5,6-dihydrobenz(c) acridine-7-carboxylic acids and related compounds as immunosuppressive agents
|
|
US5126351A
(en)
|
1991-01-24 |
1992-06-30 |
Glaxo Inc. |
Antitumor compounds
|
|
US5223506A
(en)
|
1991-06-04 |
1993-06-29 |
Glaxo Inc. |
Cyclic antitumor compounds
|
|
US5428040A
(en)
|
1993-08-31 |
1995-06-27 |
The Du Pont Merck Pharmaceutical Company |
Carbocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents
|
|
DE69430752T2
(de)
|
1993-09-28 |
2002-10-17 |
Kyowa Hakko Kogyo Co., Ltd. |
Tetracyclische verbindungen
|
|
US5807874A
(en)
|
1995-05-17 |
1998-09-15 |
Rutgers, The State University Of New Jersey |
Trisbenzimidazoles useful as topoisomerase I inhibitors
|
|
CA2221248A1
(en)
|
1995-05-17 |
1996-11-21 |
Leroy Fong Liu |
Tribenzimidazoles useful as topoisomerase i inhibitors
|
|
US5767142A
(en)
|
1996-03-20 |
1998-06-16 |
Rutgers, The State University Of New Jersey |
Trisbenzimidazoles useful as topoisomerase I inhibitors
|
|
PL328402A1
(en)
|
1996-02-12 |
1999-01-18 |
Rutgers |
Analoques of coralline as inhibitors of topoisomerase
|
|
US5770617A
(en)
|
1996-03-20 |
1998-06-23 |
Rutgers, The State University Of New Jersey |
Terbenzimidazoles useful as antifungal agents
|
|
BR9711296A
(pt)
|
1996-09-23 |
1999-08-17 |
Univ Rutgers |
Composto processo terap-utico para inibir o crescimento de c-lulas de c ncer e composi-Æo farmac-utica
|
|
US6140328A
(en)
|
1997-12-12 |
2000-10-31 |
Rutgers, The State University Of New Jersey |
Heterocyclic cytotoxic agents
|
|
WO2000021537A1
(en)
|
1998-10-14 |
2000-04-20 |
Purdue Research Foundation |
Novel indenoisoquinolines as antineoplastic agents
|
|
WO2001032631A2
(en)
|
1999-10-29 |
2001-05-10 |
Rutgers, The State University Of New Jerey |
Heterocyclic cytotoxic agents
|
|
US6740650B2
(en)
|
1999-10-29 |
2004-05-25 |
Rutgers, The State University Of New Jersey |
Heterocyclic cytotoxic agents
|
|
CA2467279A1
(en)
|
2001-11-14 |
2003-06-26 |
Edmond J. Lavoie |
Solubilized topoisomerase poison agents
|
|
DE60225943T2
(de)
|
2001-11-14 |
2009-01-29 |
Rutgers, The State University |
Topoisomerase-giftmittel
|
|
ATE405568T1
(de)
|
2001-11-14 |
2008-09-15 |
Univ Rutgers |
Cytotoxische mittel
|
|
AU2002363658B2
(en)
|
2001-11-14 |
2008-09-11 |
Rutgers, The State University |
Solubilized topoisomerase poisons
|
|
US6989387B2
(en)
|
2002-08-09 |
2006-01-24 |
Rutgers, The State University Of New Jersey |
Nitro and amino substituted topoisomerase agents
|
|
AU2003268075A1
(en)
|
2002-08-09 |
2004-02-25 |
Edmond J. Lavoie |
Nitro and amino substituted dibenzonaphthyridines as topoisomerase agents
|
|
US6992088B2
(en)
|
2002-08-09 |
2006-01-31 |
Rutgers, The State University Of New Jersey |
Nitro and amino substituted heterocycles as topoisomerase I targeting agents
|
|
AU2003290818A1
(en)
|
2002-11-12 |
2004-06-03 |
Edmond J. Lavoie |
Topoisomerase-targeting agents
|
|
ES2605443T3
(es)
|
2003-11-06 |
2017-03-14 |
Seattle Genetics, Inc. |
Conjugados de auristatina con anticuerpos anti-HER2 o anti-CD22 y su uso en terapia
|
|
WO2006065448A2
(en)
|
2004-11-18 |
2006-06-22 |
Threshold Pharmaceuticals, Inc. |
Topoisomerase inhibitors and prodrugs
|
|
ZA200800314B
(en)
|
2005-06-29 |
2009-09-30 |
Threshold Pharmaceuticals Inc |
Phosphoramidate alkylator prodrugs
|
|
JP2010519310A
(ja)
*
|
2007-02-21 |
2010-06-03 |
メダレックス インコーポレイテッド |
単一のアミノ酸を有する化学リンカーおよびその複合体
|
|
PE20090245A1
(es)
*
|
2007-05-08 |
2009-03-17 |
Genentech Inc |
Anticuerpos anti-muc16 disenados con cisteina y conjugados de anticuerpos y farmacos
|
|
TW201038578A
(en)
|
2009-01-30 |
2010-11-01 |
Univ Rutgers |
Methods to treat cancer
|
|
JP5773888B2
(ja)
|
2009-03-06 |
2015-09-02 |
ラットガーズ,ザ・ステート・ユニバーシティ・オブ・ニュージャージー |
癌治療に用いられるメチレンジオキシベンゾ[i]フェナントリジン誘導体
|
|
WO2010127363A1
(en)
*
|
2009-05-01 |
2010-11-04 |
Rutgers, The State University Of New Jersey |
Toposiomerase inhibitors
|
|
US20130280282A1
(en)
*
|
2012-04-24 |
2013-10-24 |
Daiichi Sankyo Co., Ltd. |
Dr5 ligand drug conjugates
|
|
CN104822656B
(zh)
*
|
2012-05-15 |
2018-05-01 |
西雅图基因公司 |
自稳定接头偶联物
|
|
US9580511B2
(en)
|
2013-03-11 |
2017-02-28 |
Genzyme Corporation |
Site-specific antibody-drug conjugation through glycoengineering
|